StephenJ.MeltzerMD

Gastroenterology • Baltimore, MD

Professor of Medicine, Professor of Oncology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Meltzer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Meltzer's full profile

Already have an account?

Office
1800 Orleans Street
Baltimore, MD 21287
Phone+1 410-955-5000

Fax+1 410-955-5001

Education & Training

Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalFellowship, Gastroenterology, 1984 - 1985
University of ColoradoFellowship, Gastroenterology, 1983 - 1984
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 1980 - 1982
Tulane UniversityInternship, Internal Medicine, 1979 - 1980
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1979

Certifications & Licensure

CA State Medical License 1985 - Present
MD State Medical License 1988 - 2025
CO State Medical License 1982 - 1985
LA State Medical License 1979 - 1983
TX State Medical License 1980 - 1983
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Elected Member The American Society for Clinical Investigation, 1997

Clinical Trials

EsophaCap for the Detection of Early Esophageal Carcinoma Start of enrollment: 2016 Jan 12
Recruiting
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: themulticentre study.
Jinsei Miyoshi, Alessandro Mannucci, Marco Scarpa, Feng Gao, Shusuke Toden
Gut. 2024-11-19
Neoplastic Progression Risk in Females With Barrett's Esophagus: A Systematic Review and Meta-Analysis of Individual Patient Data.
Pauline A Zellenrath, Laurelle van Tilburg, Roos E Pouw, Rena Yadlapati, Yonne Peters
Clinical Gastroenterology and Hepatology. 2024-10-05
Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett's Esophagus.
Sarah Laun, Francia Pierre, Suji Kim, Daniel Lunz, Tara Maddala
Diagnostics. 2024-09-10

Journal Articles

Inhibition of the miR-192/215–Rab11-FIP2 Axis Suppresses Human Gastric Cancer Progression
Stephen Meltzer, MD, Nature

Press Mentions

Barrett’s Esophagus Prognostic Test Highlighted at Scientific MeetingOctober 29th, 2024
Previse Showcases New Data Highlighting Clinical Utility of Esopredict® Barrett's Esophagus Prognostic Test at ACG 2024October 28th, 2024
Peer-Reviewed Study Validates Reliability and Reproducibility of Esopredict, Previse’s Prognostic Assay for Patients with Barrett’s EsophagusSeptember 11th, 2024
Join now to see all

Grant Support

The Temporal Epigenomic Program Of Barrett'S Neoplastic ProgressionNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
The Role Of Microrna Alterations In Barrett'S CarcinogenesisNational Cancer Institute2009–2011
Inflammatory Bowel Disease-Associated Malignant TransformationNational Cancer Institute2009–2011
Comprehensive Biomarker Development In Early EsophagogasNational Cancer Institute2006–2009
The Human Colorectal InstabilitomeNational Cancer Institute2006–2007
Neoplastic Complications In Inflammatory Bowel DiseaseNational Cancer Institute2006–2007
Genomics: Esophageal Metaplasia-Associated MalignancyNational Cancer Institute2006
Neoplastic Complications In Inflammatory Bowel DiseaseNational Cancer Institute2003–2006
Research Training In GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2005
Validation Studies Of Circulating Methylation BiomarkersNational Cancer Institute2005
Comprehensive Biomarker Development In Early EsophagogasNational Cancer Institute2004–2005
The Human Colorectal InstabilitomeNational Cancer Institute2003–2005
Novel Methylation Targets In Gastric CancerNational Cancer Institute2003–2005
Genomics: Esophageal Metaplasia-Associated MalignancyNational Cancer Institute2002–2005
Comprehensive Biomaker Development In Early EsophagogastNational Cancer Institute1999–2003
Human Colorectal InstabilitomeNational Cancer Institute1998–2002
Neoplastic Complications In Inflammatory Bowel DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1993–2001
Igfir In Human GI TumorsNational Cancer Institute1998–2000
Nitric Oxide In Helicobacter-Associated Gastric CancerNational Cancer Institute1995–1997